Pulike Biological Engineering, Inc. (SHA:603566)
China · Delayed Price · Currency is CNY 10.36
+0.12 (1.17%)
Jun 23, 2026, 2:04 PM CST
SHA:603566 Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, SHA:603566 stock has a consensus rating of "Strong Buy" and an average price target of ¥15.44. The average 1-year stock price forecast is 49.03% higher than the current stock price, while the lowest is ¥14.50 (+39.96%) and the highest is ¥16.82 (+62.36%).
Price Target: ¥15.44 (+49.03%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SHA:603566 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Jan '26 | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 2 | 2 | 3 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 4 | 3 | 2 | 3 |
Financial Forecast
Revenue This Year
1.10B
from 1.09B
Increased by 0.70%
Revenue Next Year
1.32B
from 1.10B
Increased by 19.82%
EPS This Year
0.69
from 0.36
Increased by 91.67%
EPS Next Year
0.82
from 0.69
Increased by 18.84%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.1B | ||
| Avg | 1.1B | ||
| Low | 1.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.9% | ||
| Avg | 0.7% | ||
| Low | -0.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.69 | ||
| Avg | 0.69 | ||
| Low | 0.69 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 91.7% | ||
| Avg | 91.7% | ||
| Low | 91.7% |